Related Experiment Video
Updated: May 22, 2026

04:22
Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
Dual platform spatial transcriptomics reveals parvalbumin interneuron subtype vulnerability in mouse models of
Heewon Seo1, Dylan J Terstege2,3, Yi Ren2,3
1Applied Spatial Omics Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Nature Communications
|May 20, 2026
Summary
Alzheimer's disease impacts specific brain cells in the retrosplenial cortex. Spatial transcriptomics reveals molecular changes in vulnerable parvalbumin-expressing interneurons, offering new insights into disease mechanisms.
Area of Science:
- Neuroscience
- Genomics
- Molecular Biology
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder causing cognitive decline.
- The retrosplenial cortex (RSC) and its parvalbumin-expressing (PV+) interneurons are early sites of AD pathology.
- Understanding molecular changes in these vulnerable neurons is crucial.
Purpose of the Study:
- To investigate molecular alterations in PV+ interneurons within the RSC in a mouse model of AD.
- To identify distinct transcriptional subpopulations and disease-associated molecular markers.
- To demonstrate the utility of integrated spatial transcriptomics platforms.
Main Methods:
- Utilized a dual-platform spatial transcriptomics approach: GeoMx Digital Spatial Profiler (DSP) and Xenium In Situ.
- Analyzed transcriptomic profiles of PV+ and NeuN+ neurons in the RSC of female 5xFAD mice.
- Employed non-negative matrix factorization and k-means clustering to identify disease-associated metagenes.
Main Results:
- Identified distinct transcriptional subpopulations within RSC PV+ interneurons.
- Found significant down-regulation of Dner, Gad1, and Pvalb in transgenic (TG) mice, indicating impaired GABAergic signaling.
- Confirmed findings through cross-validation with RNAscope and immunohistochemistry, ensuring robustness.
Conclusions:
- PV+ interneurons exhibit heterogeneity and molecular vulnerabilities in Alzheimer's disease.
- The study highlights specific molecular markers associated with AD pathology in these neurons.
- Integrated spatial transcriptomics is a powerful tool for discovering disease-associated neuronal subtypes.

